COSCIENS Biopharma Inc. historical data
| Date | Open | High | Low | Close | Adj. close | Volume |
|---|---|---|---|---|---|---|
| 2023-12-06 | 3.070 | 3.080 | 3.070 | 3.080 | 36.960 | 393 |
| 2023-12-05 | 2.770 | 2.920 | 2.770 | 2.920 | 35.040 | 728 |
| 2023-12-04 | 2.710 | 2.900 | 2.710 | 2.900 | 34.800 | 2,115 |
| 2023-11-30 | 2.750 | 2.750 | 2.650 | 2.650 | 31.800 | 203 |
| 2023-11-29 | 2.710 | 2.710 | 2.710 | 2.710 | 32.520 | 1,490 |
| 2023-11-28 | 2.980 | 2.980 | 2.710 | 2.710 | 32.520 | 940 |
| 2023-11-27 | 3.070 | 3.070 | 2.900 | 2.990 | 35.880 | 3,954 |
| 2023-11-24 | 2.610 | 3.060 | 2.600 | 3.060 | 36.720 | 7,265 |
| 2023-11-23 | 3.000 | 3.200 | 2.600 | 2.670 | 32.040 | 8,789 |
| 2023-11-22 | 2.480 | 2.480 | 2.480 | 2.480 | 29.760 | 292 |
| 2023-11-21 | 2.350 | 2.500 | 2.350 | 2.380 | 28.560 | 1,530 |
| 2023-11-20 | 2.190 | 2.190 | 2.190 | 2.190 | 26.280 | 255 |
| 2023-11-16 | 2.140 | 2.210 | 2.140 | 2.210 | 26.520 | 3,414 |
| 2023-11-15 | 1.990 | 2.080 | 1.970 | 2.030 | 24.360 | 1,000 |
| 2023-11-14 | 2.100 | 2.100 | 2.090 | 2.100 | 25.200 | 500 |
| 2023-11-13 | 2.050 | 2.080 | 2.050 | 2.050 | 24.600 | 428 |
| 2023-11-10 | 2.000 | 2.070 | 2.000 | 2.070 | 24.840 | 400 |
| 2023-11-09 | 2.160 | 2.160 | 1.960 | 2.150 | 25.800 | 1,000 |
| 2023-11-08 | 2.140 | 2.140 | 2.140 | 2.140 | 25.680 | 204 |
| 2023-11-03 | 2.180 | 2.180 | 2.180 | 2.180 | 26.160 | 118 |
| 2023-11-02 | 2.150 | 2.150 | 2.100 | 2.100 | 25.200 | 700 |
| 2023-11-01 | 2.070 | 2.070 | 1.910 | 1.910 | 22.920 | 1,000 |
| 2023-10-31 | 2.010 | 2.140 | 2.000 | 2.140 | 25.680 | 2,401 |
| 2023-10-30 | 2.190 | 2.190 | 1.920 | 1.920 | 23.040 | 2,773 |
| 2023-10-27 | 2.100 | 2.100 | 2.100 | 2.100 | 25.200 | 125 |
| 2023-10-25 | 2.100 | 2.100 | 2.100 | 2.100 | 25.200 | 1,000 |
| 2023-10-23 | 2.150 | 2.150 | 2.150 | 2.150 | 25.800 | 588 |
| 2023-10-20 | 2.350 | 2.400 | 2.150 | 2.150 | 25.800 | 1,000 |
| 2023-10-19 | 2.380 | 2.390 | 2.230 | 2.230 | 26.760 | 500 |
| 2023-10-18 | 2.310 | 2.310 | 2.310 | 2.310 | 27.720 | 983 |
| 2023-10-17 | 2.500 | 2.500 | 2.450 | 2.450 | 29.400 | 754 |
| 2023-10-16 | 2.470 | 2.500 | 2.450 | 2.460 | 29.520 | 1,020 |
| 2023-10-13 | 2.460 | 2.610 | 2.350 | 2.610 | 31.320 | 3,900 |
| 2023-10-12 | 2.500 | 2.500 | 2.460 | 2.460 | 29.520 | 600 |
| 2023-10-11 | 2.590 | 2.590 | 2.455 | 2.500 | 30.000 | 400 |
| 2023-10-10 | 2.800 | 2.830 | 2.700 | 2.700 | 32.400 | 6,390 |
| 2023-10-06 | 3.000 | 3.000 | 2.780 | 2.800 | 33.600 | 4,600 |
| 2023-10-05 | 3.020 | 3.020 | 3.020 | 3.020 | 36.240 | 510 |
| 2023-10-04 | 3.030 | 3.030 | 3.030 | 3.030 | 36.360 | 204 |
| 2023-10-03 | 3.210 | 3.210 | 3.030 | 3.030 | 36.360 | 952 |
| 2023-10-02 | 3.320 | 3.360 | 3.280 | 3.360 | 40.320 | 450 |
| 2023-09-26 | 3.350 | 3.400 | 3.350 | 3.360 | 40.320 | 2,500 |
| 2023-09-25 | 3.250 | 3.250 | 3.250 | 3.250 | 39.000 | 100 |
| 2023-09-22 | 3.370 | 3.370 | 3.260 | 3.340 | 40.080 | 1,220 |
| 2023-09-21 | 3.370 | 3.450 | 3.370 | 3.450 | 41.400 | 500 |
| 2023-09-20 | 3.470 | 3.620 | 3.350 | 3.620 | 43.440 | 3,903 |
| 2023-09-19 | 3.540 | 3.540 | 3.540 | 3.540 | 42.480 | 461 |
| 2023-09-15 | 3.550 | 3.550 | 3.550 | 3.550 | 42.600 | 540 |
| 2023-09-14 | 3.420 | 3.490 | 3.420 | 3.470 | 41.640 | 327 |
| 2023-09-13 | 3.440 | 3.540 | 3.440 | 3.450 | 41.400 | 300 |
| 2023-09-11 | 3.400 | 3.400 | 3.360 | 3.360 | 40.320 | 391 |
| 2023-09-08 | 3.390 | 3.390 | 3.390 | 3.390 | 40.680 | 115 |
| 2023-09-07 | 3.420 | 3.420 | 3.410 | 3.410 | 40.920 | 1,312 |
| 2023-09-06 | 3.480 | 3.500 | 3.420 | 3.420 | 41.040 | 900 |
| 2023-09-05 | 3.450 | 3.480 | 3.450 | 3.480 | 41.760 | 1,144 |
| 2023-09-01 | 3.600 | 3.600 | 3.550 | 3.550 | 42.600 | 646 |
| 2023-08-31 | 3.600 | 3.600 | 3.450 | 3.450 | 41.400 | 652 |
| 2023-08-30 | 3.650 | 3.650 | 3.570 | 3.570 | 42.840 | 1,535 |
| 2023-08-28 | 3.800 | 3.800 | 3.650 | 3.650 | 43.800 | 900 |
| 2023-08-25 | 3.650 | 3.650 | 3.650 | 3.650 | 43.800 | 700 |
Stock splits
No stock splits on record.
Dividends
No dividends on record.
Open, high, low and close are as traded (CAD). Adjusted close accounts for splits and dividends. Educational only, not financial advice.